You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

muscle invasive

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Sensitivity of Multiparametric MRI in Differentiation Between

Recruiting
  • Cancer, Bladder
  • multiparametric MRI on the bladder
  • diagnostic cystoscopy +/- TURBT
  • Badr, Cairo, Egypt
    Faculty of medicine, Helwan university
Jun 26, 2022

Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Jan 17, 2023

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

Terminated
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • Hyaluronic Acid (HA) sodium salt and Hydeal-D
  • Rozzano, Mi, Italy
    Humanitas Research Hospital
Sep 29, 2023

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Urothelial Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Nov 23, 2022

Bladder Cancer Trial in Roskilde (Urine test)

Recruiting
  • Bladder Cancer
    • Roskilde, Denmark
      Zealand University Hospital
    Oct 5, 2022

    Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

    Not yet recruiting
    • Urinary Bladder Neoplasms
      • (no location specified)
      Feb 14, 2023

      Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)

      Recruiting
      • Urinary Bladder Cancer
      • Carboplatin-Gemcitabine Cisplatin-Gemcitabine
      • Assiut, Egypt
        AssiutU
      Apr 22, 2023

      High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma, Perfusion; Complications, Intraoperative Complications Trial

      Recruiting
      • High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
      • +2 more
      • hyperthermic intravesical perfusion
      • Zhengzhou, Henan, China
        BR-PRG
      Sep 15, 2022

      Toxicity Trial in Ghent (Adjuvant EBRT)

      Completed
      • Toxicity
      • Adjuvant EBRT
      • Ghent, Belgium
        Dept of Radiotherapy, University Hospital Ghent
      Dec 23, 2022

      Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)

      Recruiting
      • Muscle-Invasive Bladder Carcinoma
      • Metastasis directed therapy (MDT)
      • +2 more
      • Ghent, Belgium
        Ghent University Hospital
      Dec 3, 2022

      Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

      Recruiting
      • Urothelial Carcinoma
      • +2 more
        • Recife, Pernambuco, Brazil
        • +6 more
        Jul 11, 2023

        Non-Muscle Invasive Bladder Cancer Trial in Aarhus (Laser ablation)

        Recruiting
        • Non-Muscle Invasive Bladder Cancer
        • Laser ablation
        • Aarhus, Denmark
          Aarhus University Hospital
        Aug 5, 2022

        Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)

        Recruiting
        • Bladder Cancer
        • Non-muscle Invasive
        • Biel, Switzerland
          Roland Seiler
        Nov 17, 2022

        Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

        Not yet recruiting
        • Non-Muscle Invasive Bladder Cancer
        • HER2
        • (no location specified)
        Jul 16, 2023

        Urine-based Molecular Testing vs Cystoscopy for Surveillance of

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • +2 more
        • CxBladder Monitor
        • Cystoscopy
        • Scottsdale, Arizona
        • +2 more
        Nov 14, 2023

        Clinical Performance Evaluation of the C2i Test

        Not yet recruiting
        • Muscle Invasive Bladder Cancer
        • C2i-WGS-MRD Test
        • (no location specified)
        May 5, 2023

        Muscle-Invasive Bladder Carcinoma Trial in Utrecht (Prehabilitation)

        Not yet recruiting
        • Muscle-Invasive Bladder Carcinoma
        • Prehabilitation
        • (no location specified)
        Jul 27, 2022

        Bladder Cancer Stage II Trial in Los Angeles (MRI imaging of the pelvis/bladder, genomic analysis of tumor)

        Recruiting
        • Bladder Cancer Stage II
        • MRI imaging of the pelvis/bladder
        • genomic analysis of tumor
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Sep 27, 2022

        Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • BCG combined with Tislelizumab
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        Oct 12, 2022

        Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

        Recruiting
        • Muscle Invasive Bladder Carcinoma
        • +2 more
        • Lymphadenectomy
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 9, 2023

        Non-muscle Invasive Bladder Cancer Trial (TARA-002)

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • TARA-002
        • (no location specified)
        Aug 24, 2022

        Older Muscle-Invasive Bladder Cancer After Radical Cystectomy

        Not yet recruiting
        • Urinary Bladder Cancer
          • (no location specified)
          Aug 31, 2022

          To Better Understand Most Important Factors for Patients When

          Recruiting
          • Muscle Invasive Bladder Cancer
          • +4 more
          • Discrete Choice Experiment (DCE) Patients DCE Questionnaire
          • Semi-Structured Interview Patients Interview
          • London, United Kingdom
            Guy's and St Thomas' NHS Foundation Trust
          Oct 20, 2022